SFCvalves Profile Banner
SFC - Valvulopathies Profile
SFC - Valvulopathies

@SFCvalves

Followers
164
Following
113
Media
0
Statuses
314

Joined May 2022
Don't wanna be here? Send us removal request.
@SFCvalves
SFC - Valvulopathies
1 year
RT @hahn_rt: Tricuspid Valve lecture #SCA2024 and #AATS2024 key references: , https://t.co….
0
70
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @AboyansV: Honored to start my first day as the new Editor in Chief of the European Journal of Preventive Cardiology. Thank you to all a….
0
15
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @gbiondizoccai: Must-read review in the latest issue of The Lancet on mechanisms and management of valvular heart disease .
0
36
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @JACCJournals: From a meta-analysis of 5 studies, #TEER with the #MitraClip system appears to be equally safe and effective in patients….
0
15
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @EuroInterventio: This study focused on the impact of the timing of bioprosthetic valve fracture (BVF) on the long-term outcomes of THVs….
0
24
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @gbiondizoccai: Secondary mitral regurgitation (SMR) is a heterogeneous disease entity presenting with different clinical phenotypes. Di….
0
21
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @echocardiac: In mitral regurgitation, temporal variation of MR flow has been considered an important reason for inaccurate MR grading.….
0
13
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @KristinaHaugaa: Are mitral valve prolapse and disjunction players in idiopathic ventricular fibrillation? @eivindaabel @ProCardio1 @ESC….
0
30
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @hahn_rt: Prosthesis-patient mismatch post-SAVR: FREE for 50 days: See also: and https:/….
0
19
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @JACCJournals: This multicenter, observational, #JACCINT study of 147 pts who underwent #TTVR screening, reported screening failure of 7….
0
15
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @ehj_ed: Transcatheter treatment of the tricuspid valve: current status and perspectives. A State-of-the-Art Review just published in #E….
0
79
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @CircAHA: Establishment of #hiPSC differentiation into functional heart valve endothelial like cells #hiVECs & valve interstitial like c….
0
1
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @ehj_ed: Shortening in-hospital stay after transcatheter aortic valve implantation: a déjà vu in percutaneous interventions. Read the la….
0
16
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @guilbon: #THT2024 In the context of tricuspid regurgitation related to a pacemaker lead, there's always a risk in removing the lead. Ho….
0
8
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @JACCJournals: The new issue of #JACCIMG is out!. In aortic stenosis, #echofirst LV mechanical dispersion (MD) provides prognostic value….
0
11
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @EuroInterventio: This study finds that in atrial functional mitral regurgitation (AFMR) patients, optimal MR reduction (≤1+) post-TEER….
0
10
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @purviparwani: Wow great #Echofirst case from 🇮🇳 with Acute rheumatic fever with an AML mass consistent with hypertrophic Aschoff nodule….
0
8
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @PPibarot: Limitations of NOTION: TAVR with SEV of first generation: SAVR valves: 35% were Trifecta or Mitroflow; major survivorship bia….
0
3
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @PPibarot: NOTION 10 years: Similar rates of stroke mortality and all-cause BVF so valve durability in TAVR vs. SAVR. Reassuring result….
0
16
0
@SFCvalves
SFC - Valvulopathies
1 year
RT @CardioOnline: La SFC témoigne de sa tristesse et de sa douleur mais aussi de son immense fierté d’avoir compté parmi elle le Pr Alain C….
0
6
0